 |
   
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
International News Abbott Laboratories Asks Regulators to Approve New Dose of AIDS Drug Kaletra for ChildrenJuly 23, 2007 Abbott Laboratories on Friday said it is seeking approval from the U.S. Food and Drug Administration and European regulators for lower-dose versions of its AIDS drug Kaletra, which is also marketed as Aluvia. The new version is expected to be suitable for pediatric use and would cost half as much as the full-strength formulation. Associated Press 7.20.2007  This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
|
|
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
